Navigation Links
Reportlinker Adds Top Ten World's Leading Life Science Intermediates Companies
Date:11/16/2010

NEW YORK, Nov. 16, 2010 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

http://www.reportlinker.com/p0169972/Top-Ten-Worlds-Leading-Life-Science-Intermediates-Companies.html

A strategic assessment of the competitive environment is widely recognized as one of the highest priority management responsibilities, the task crucial to business survival, growth and profitability. Timely and factual competitive intelligence is vital to the success of all business functions, particularly Planning, Marketing, R&D, and Manufacturing.

In a highly dynamic and fragmented life science intermediates market, besieged by intense competition and rapid pace of technological innovations, the ability to anticipate new competitive product introductions and marketing strategies is particularly important... and can spell the difference between success and failure.

This unique multi-client study was prepared by Venture Planning Group in order to provide industry executives with strategically significant competitor information, analysis and insight crucial to the development and implementation of effective business, marketing and R&D programs. The study's major objectives include:

  • To establish a comprehensive, factual and cost-effective information base on performance, capabilities, goals and strategies of the world's leading life science intermediates companies.
  • To help current suppliers realistically assess their financial, technological and marketing capabilities vis-a-vis leading competitors.
  • To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates.
  • To complement organizations' internal competitor information gathering efforts with strategic analysis, data interpretation and insight.

  • The Top 10 report is based on a combination of primary and secondary information sources, including Venture Planning Group's proprietary database, developed during the firm's continuous monitoring of the industry, as well as over 100 syndicated multiclient studies and numerous proprietary single-client assignments. This database contains information on major life science intermediates companies, technologies, products and executives worldwide. Moreover, a comprehensive review of the Top 10 companies' product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted.

    Contains 600 pages and 84 tables

    SECTION I. EXECUTIVE SUMMARY

    - A 3-5 page synopsis of main sections.

    SECTION II. BUSINESS ORGANIZATION

    - History of the life science intermediates business

    evolution, important to the understanding of the

    corporate culture, management mentality and strategies.

    - Recent acquisitions, divestitures and significant

    organizational changes.

    - Current organizational structure.

    SECTION III. SENIOR MANAGEMENT

    - Background of key executives.

    SECTION IV. FACILITIES AND EMPLOYEES

    - Major administrative, manufacturing

    and R&D facilities in the U.S. and abroad.

    - New plants under construction.

    - U.S. and international work force size and distribution.

    SECTION V.TECHNOLOGICAL KNOW-HOW

    - Internally developed and acquired technologies, and

    related capabilities.

    - Proprietary technologies and patent litigations.

    SECTION VI. PRODUCT PORTFOLIO

    - Extensive review of major product lines.

    - New product introductions and line extensions.

    SECTION VII. MARKETING TACTICS

    - Major promotional strategies.

    - Distribution approaches.

    - Product service and support.

    SECTION VIII. FINANCIAL ANALYSIS

    - Sales and operating profit by division, product line,

    geographic region and country.

    - Five-year sales and profit performance.

    SECTION IX. R&D EXPENDITURES AND MAJOR

    PROGRAMS

    - Estimated R&D budget.

    - Research facilities and staff.

    - New technologies, products and applications in

    development.

    SECTION X. COLLABORATIVE ARRANGEMENTS

    - Major joint venture, distribution, OEM and licensing

    partners, both industrial and academic.

    - Terms of collaborative agreements and specific products

    involved.

    SECTION XI. STRATEGIC DIRECTION

    - Specific business, new product development and

    marketing strategies.

    - Strengths and weaknesses.

    - Anticipated acquisitions, joint ventures and divestitures.

    Comparative Analysis

    In this section of the report, the Top 10 companies are

    ranked according to the following criteria:

    - Estimated sales in Europe, North America, Asia,

    and other geographic regions.

    - Operating profit.

    - R&D expenditures.

    List of TablesTABLE BF-1: BASF SALES AND OPERATING

    PROFIT GROWTH

    TABLE BF-2: BASF SALES BY BUSINESS SEGMENT

    TABLE BF-3: BASF SALES GROWTH BY BUSINESS

    SEGMENT

    TABLE BF-4: BASF OPERATING PROFIT BY

    BUSINESS SEGMENT

    TABLE BF-5: BASF PLASTICS SALES BY DIVISION

    TABLE BF-6: BASF PERFORMANCE PRODUCTS

    SALES BY DIVISION

    TABLE BF-7: BASF CHEMICAL SALES BY

    DIVISION

    TABLE BF-8: BASF AGRICULTURAL PRODUCTS

    AND NUTRITION SALES BY

    DIVISION

    TABLE BF-9: BASF SALES BY GEOGRAPHIC

    REGION

    TABLE BR-1: BAYER SALES BY BUSINESS

    SEGMENT

    TABLE BR-2: BAYER SALES GROWTH BY

    BUSINESS SEGMENT

    TABLE BR-3: BAYER SALES BY GEOGRAPHIC

    REGION

    TABLE BR-4: BAYER SALES GROWTH BY

    GEOGRAPHIC REGION

    TABLE BR-5: LANXESS SALES AND OPERATING

    PROFIT GROWTH

    TABLE BR-6: LANXESS SALES BY PRODUCT LINE

    TABLE BR-7: LANXESS SALES GROWTH BY

    PRODUCT LINE

    TABLE CX-1: CAMBREX SALES AND OPERATING

    PROFIT GROWTH

    TABLE CX-2: CAMBREX SALES BY BUSINESS

    SEGMENT

    TABLE CX-3: CAMBREX SALES GROWTH BY

    BUSINESS SEGMENT

    TABLE CX-4: CAMBREX OPERATING PROFIT

    AND MARGINS BY BUSINESS

    SEGMENT

    TABLE CX-5: CAMBREX OPERATING PROFIT

    GROWTH BY BUSINESS SEGMENT

    TABLE CX-6: CAMBREX SALES BY PRODUCT

    GROUP

    TABLE CX-7: CAMBREX SALES GROWTH BY

    PRODUCT GROUP

    TABLE CX-8: CAMBREX SALES BY GEOGRAPHIC

    REGION

    TABLE CX-9: CAMBREX SALES GROWTH BY

    GEOGRAPHIC REGION

    TABLE CL-1: CLARIANT SALES BY DIVISION

    TABLE CL-2: CLARIANT SALES GROWTH BY

    DIVISION

    TABLE CL-3: CLARIANT PROFIT BY DIVISION

    TABLE CL-4: CLARIANT PROFIT GROWTH BY

    DIVISION

    TABLE CL-5: CLARIANT SALES BY GEOGRAPHIC

    REGION

    TABLE DE-1: EVONIK SALES AND OPERATING

    PROFIT GROWTH

    TABLE DE-2: EVONIK SALES BY DIVISION

    TABLE DE-3: EVONIK SALES GROWTH BY

    DIVISION

    TABLE DE-4: EVONIK FINE AND INDUSTRIAL

    CHEMICAL SALES BY BUSINESS

    UNIT

    TABLE DE-5: EVONIK COATINGS AND

    ADVANCED FILLERS SALES BY

    BUSINESS UNIT

    TABLE DE-6: EVONIK PERFORMANCE

    MATERIALS SALES BY BUSINESS

    UNIT

    TABLE DE-7: EVONIK CONSTRUCTION

    CHEMICALS SALES BY BUSINESS

    UNIT

    TABLE DE-8: EVONIK SPECIALTY POLYMERS

    SALES BY BUSINESS UNIT

    TABLE DE-9: EVONIK SALES BY GEOGRAPHIC

    REGION AND COUNTRY

    TABLE DO-1: DOW CHEMICAL SALES AND

    OPERATING PROFIT GROWTH

    TABLE DO-2: DOW CHEMICAL SALES BY

    OPERATING SEGMENT

    TABLE DO-3: DOW CHEMICAL SALES GROWTH

    BY OPERATING SEGMENT

    TABLE DO-4: DOW CHEMICAL SALES BY

    GEOGRAPHIC REGION

    TABLE DO-5: DOW CHEMICAL SALES GROWTH

    BY GEOGRAPHIC REGION

    TABLE DM-1: DSM SALES AND OPERATING

    PROFIT GROWTH

    TABLE DM-2: DSM SALES BY DIVISION

    TABLE DM-3: DSM SALES GROWTH BY DIVISION

    TABLE DM-4: DSM OPERATING PROFIT BY

    DIVISION

    TABLE DM-5: DSM OPERATING PROFIT

    GROWTH BY DIVISION

    TABLE DM-6: DSM LIFE SCIENCE PRODUCTS

    SALES BY BUSINESS GROUP

    TABLE DM-7: DSM LIFE SCIENCE PRODUCTS

    SALES GROWTH BY BUSINESS

    GROUP

    TABLE DM-8: DSM PERFORMANCE MATERIALS

    SALES BY BUSINESS GROUP

    TABLE DM-9: DSM PERFORMANCE MATERIALS

    SALES GROWTH BY BUSINESS

    GROUP

    TABLE DM-10: DSM INDUSTRIAL CHEMICALS

    SALES BY BUSINESS GROUP

    TABLE DM-11: DSM INDUSTRIAL CHEMICALS

    SALES GROWTH BY BUSINESS

    GROUP

    TABLE DS-1: GROUPE NOVASEP PROFORMA

    SALES BY CUSTOMER GROUP

    TABLE LO-1: LONZA SALES AND OPERATING

    PROFIT GROWTH

    TABLE LO-2: LONZA SALES BY DIVISION

    TABLE LO-3: LONZA SALES GROWTH BY

    DIVISION

    TABLE LO-4: LONZA OPERATING PROFIT BY

    DIVISION

    TABLE LO-5: LONZA OPERATING PROFIT

    GROWTH BY DIVISION

    TABLE LO-6: LONZA EXCLUSIVE SYNTHESIS &

    BIOPHARMACEUTICAL DIVISION

    SALES BY MOLECULAR SIZE

    TABLE LO-7: LONZA EXCLUSIVE SYNTHESIS &

    BIOPHARMACEUTICAL DIVISION

    SALES GROWTH BY MOLECULAR

    SIZE

    TABLE LO-8: LONZA SALES BY GEOGRAPHIC

    REGION

    TABLE LO-9: LONZA SALES GROWTH BY

    GEOGRAPHIC REGION

    TABLE LO-10: LONZA EXCLUSIVE SYNTHESIS &

    PHARMACEUTICALS SALES BY

    GEOGRAPHIC REGION

    TABLE LO-11: LONZA EXCLUSIVE SYNTHESIS &

    PHARMACEUTICALS SALES

    GROWTH BY GEOGRAPHIC

    REGION

    TABLE LO-12: LONZA ORGANIC FINE &

    PERFORMANCE CHEMICALS SALES

    BY GEOGRAPHIC REGION

    TABLE LO-13: LONZA ORGANIC FINE &

    PERFORMANCE CHEMICALS SALES

    GROWTH BY GEOGRAPHIC

    REGION

    TABLE LO-14: LONZA POLYMER INTERMEDIATES

    SALES BY GEOGRAPHIC REGION

    TABLE LO-15: LONZA POLYMER INTERMEDIATES

    SALES GROWTH BY GEOGRAPHIC

    REGION

    TABLE RH-1: RHODIA SALES AND OPERATING

    PROFIT GROWTH

    TABLE RH-2: RHODIA SALES BY ENTERPRISE

    TABLE RH-3: RHODIA SALES GROWTH

    BY ENTERPRISE

    TABLE RH-4: RHODIA OPERATING PROFIT AND

    MARGINS BY ENTERPRISE

    TABLE RH-5: RHODIA OPERATING PROFIT

    GROWTH BY ENTERPRISE

    TABLE RH-6: RHODIA SALES BY GEOGRAPHIC

    REGION AND COUNTRY

    TABLE RH-7: RHODIA SALES GROWTH BY

    GEOGRAPHIC REGION AND

    COUNTRY

    To order this report:Pharmaceutical Industry: Pharmaceutical Business News

    More  Market Research Report

    Check our  Company Profile, SWOT and Revenue Analysis!Contact:Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626
    '/>"/>

    SOURCE Reportlinker
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Reportlinker Adds US Disposable Medical Supplies Market Report
    2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
    3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
    4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
    5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
    6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
    7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
    8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
    9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
    10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
    11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/8/2016)... , Feb. 8, 2016 In a historic vote among ... plans to construct a medical cannabis cultivation facility and dispensary on tribal ... of New York as a provider for patients in the ... York as a provider for patients in the state,s Medical ... 29% (34) to approve the project and pursue designation from the ...
    (Date:2/8/2016)... , Feb. 8, 2016 ... the "Knee Reconstruction Devices Market by Product ... Implants), and Geography (U.S., Canada, Eu-5, Japan, Bric, ... 2020" report to their offering. ... of the "Knee Reconstruction Devices Market by ...
    (Date:2/8/2016)... , Feb. 8, 2016  The University of ... announced today that, as part of the development ... of the first hospitals in the U.S. to start ... Muraszko , M.D., U-M,s chair of neurosurgery. ... neurosurgery. --> The BrightMatter technology from ...
    Breaking Medicine Technology:
    (Date:2/8/2016)... ... February 08, 2016 , ... ... today that nominations will be accepted February 8, 2016 through May 8, ... Awards include the Information Security Executive® of the Year, which recognizes executives ...
    (Date:2/8/2016)... , ... February 08, 2016 , ... ... wide variety of organizations. DocuSyst provides a cloud hosted environment for FileHold ... installations include integration with various 3rd party applications using the FileHold web services ...
    (Date:2/8/2016)... Gaithersburg, MD (PRWEB) , ... February 08, 2016 ... ... (AHCC) is excited to share this important news! AHCC and the Home Health ... (AHA) Coding Clinic, CMS' designee for official ICD coding guidance and clarifications, to ...
    (Date:2/8/2016)... ... ... Guruji Mahendra Kumar Trivedi is offering 3 days of accelerated personal growth ... on February 10th. During this time, people can achieve better health, greater wealth, ... from over 40 different countries as an “ordinary man with an extraordinary gift.” ...
    (Date:2/7/2016)... Clarkston, Metamora, Michigan (PRWEB) , ... February 07, ... ... correct pelvic organ prolapse with the latest techniques and the most minimally invasive ... for pelvic organ prolapse, particularly after menopause. Other risk factors include surgery to ...
    Breaking Medicine News(10 mins):